Strober B, Sofen H, Imafuku S, Paul C, Gooderham M, Spelman L, Seo SJ, Passeron T, Kisa RM, Berger V, Vritzali E, Hoyt K, Colombo MJ, Banerjee S, Augustin M, Stein Gold L, Alexis A, Thaçi D, Blauvelt A, Lebwohl M. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2023Nov.13 [cited 2024Sep.20];7(6):s241. Available from: https://dermsquared.com/skin/article/view/2360